JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M708506200 on February 15, 2008

J. Biol. Chem., Vol. 283, Issue 19, 13459-13470, May 9, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
283/19/13459    most recent
M708506200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Sayer, J. M.
Right arrow Articles by Louis, J. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sayer, J. M.
Right arrow Articles by Louis, J. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Effect of the Active Site D25N Mutation on the Structure, Stability, and Ligand Binding of the Mature HIV-1 Protease*Formula

Jane M. Sayer{ddagger}, Fengling Liu§, Rieko Ishima, Irene T. Weber§, and John M. Louis{ddagger}1

From the {ddagger}Laboratory of Chemical Physics, NIDDK, National Institutes of Health, Bethesda, Maryland 20892-0520, the §Department of Biology, Georgia State University, Atlanta, Georgia 30303, and the Department of Structural Biology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15260

All aspartic proteases, including retroviral proteases, share the triplet DTG critical for the active site geometry and catalytic function. These residues interact closely in the active, dimeric structure of HIV-1 protease (PR). We have systematically assessed the effect of the D25N mutation on the structure and stability of the mature PR monomer and dimer. The D25N mutation (PRD25N) increases the equilibrium dimer dissociation constant by a factor >100-fold (1.3 ± 0.09 µM) relative to PR. In the absence of inhibitor, NMR studies reveal clear structural differences between PR and PRD25N in the relatively mobile P1 loop (residues 79-83) and flap regions, and differential scanning calorimetric analyses show that the mutation lowers the stabilities of both the monomer and dimer folds by 5 and 7.3 °C, respectively. Only minimal differences are observed in high resolution crystal structures of PRD25N complexed to darunavir (DRV), a potent clinical inhibitor, or a non-hydrolyzable substrate analogue, Ac-Thr-Ile-Nle-r-Nle-Gln-Arg-NH2 (RPB), as compared with PR·DRV and PR·RPB complexes. Although complexation with RPB stabilizes both dimers, the effect on their Tm is smaller for PRD25N (6.2 °C) than for PR (8.7 °C). The Tm of PRD25N·DRV increases by only 3 °C relative to free PRD25N, as compared with a 22 °C increase for PR·DRV, and the mutation increases the ligand dissociation constant of PRD25N·DRV by a factor of ~106 relative to PR·DRV. These results suggest that interactions mediated by the catalytic Asp residues make a major contribution to the tight binding of DRV to PR.


Received for publication, October 12, 2007 , and in revised form, January 11, 2008.

The atomic coordinates and structure factors (codes 3BVA and 3BVB) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).

* This work was authored, in whole or in part, by National Institutes of Health staff. This work was supported, in whole or in part, by the Intramural Research Program of the NIDDK, National Institutes of Health (NIH), and NIH Grant GM62920. This work was also supported by the Molecular Basis of Disease Program, the Georgia Research Alliance, and the Georgia Cancer Coalition. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement"in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1-S4 and Table S1.

1 To whom correspondence should be addressed: Laboratory of Chemical Physics, NIDDK, NIH, Bldg. 5, Rm. B2-29, Bethesda, MD 20892-0520. Tel.: 301-594-3122; Fax: 301-480-4001; E-mail: johnl{at}intra.niddk.nih.gov.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.